Aggredyne pulls in $3M in latest financing round

04/24/2012 | American City Business Journals

Aggredyne, a biomedical diagnostics firm involved in platelet function testing, raised $3 million in a Series A convertible preferred stock funding round. The Houston firm is preparing to apply for U.S. marketing approval for its laser-light scattering platelet aggregometer, AggreGuideTM A-100, and related blood platelet tests.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC